Patients’ characteristics
| Parameter | Patients with cancer diagnosed: | Difference (%) | P value | |
| Before lockdown (March 16, 2019 to May 31, 2019) | During lockdown (March 16, 2020 to May 31, 2020) | |||
| Number of patients | 594 | 342 | −42% | |
| Reported tumor-associated symptoms at diagnosis | ||||
| No | 207 (37%) | 77 (23%) | −14% | <0.001* |
| Yes | 247 (44%) | 195 (59%) | +15% | |
| Unknown | 140 | 70 | ||
| Referral of patients | ||||
| Patients without symptoms | 109 (18%) | 53 (16%) | −2% | 0.009* |
| Patients with symptoms | 30 (5%) | 41 (12%) | +7% | |
| Specialist | 378 (64%) | 209 (61%) | −3% | |
| General practitioner | 35 (6%) | 18 (5%) | −1% | |
| Emergency | 13 (2%) | 7 (2%) | 0% | |
| Unknown | 29 | 14 | ||
| Leading co-morbidities | ||||
| None | 206 (35%) | 163 (49%) | +14% | <0.001* |
| Cardiovascular disease | 124 (21%) | 81 (24%) | +3% | |
| Malignant disease | 67 (11%) | 22 (6%) | −5% | |
| Respiratory disease | 17 (3%) | 6 (2%) | −1% | |
| Infectious disease | 3 (0.5%) | 0 | −0.5% | |
| Rheumatic disease | 5 (1%) | 2 (1%) | 0% | |
| Endocrine & metabolic | 28 (5%) | 26 (8%) | +3% | |
| Psychiatric disorders | 20 (3%) | 8 (2%) | −1% | |
| Others | 23 (4%) | 5 (2%) | −2% | |
| Unknown | 101 | 20 | ||
Symptoms, referral of patients and co-morbidities before and after lockdown.
*χ2 test.